Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial.

MLA

Bethel, M.Angelyn, et al. “Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial.” Diabetes Care, vol. 43, no. 2, Feb. 2020, pp. 446–52. EBSCOhost, https://doi.org/10.2337/dc19-1065.

APA

Bethel, M. A., Mentz, R. J., Merrill, P., Buse, J. B., Chan, J. C., Goodman, S. G., Iqbal, N., Jakuboniene, N., Katona, B., Lokhnygina, Y., Lopes, R. D., Maggioni, A. P., Ohman, P., Tankova, T., Bakris, G. L., Hernandez, A. F., & Holman, R. R. (2020). Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial. Diabetes Care, 43(2), 446–452. https://doi.org/10.2337/dc19-1065

Chicago

Bethel, M Angelyn, Robert J Mentz, Peter Merrill, John B Buse, Juliana C Chan, Shaun G Goodman, Nayyar Iqbal, et al. 2020. “Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial.” Diabetes Care 43 (2): 446–52. doi:10.2337/dc19-1065.